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We have studied the effect of the drug pactamycin on protein synthesis in polio-
virus-infected HeLa cells. At a concentration which primarily inhibits initiation of
protein synthesis, the spectrum of poliovirus proteins synthesized is markedly
changed. The amount of NCVP 1, the capsid precursor, is greatly reduced relative
to NCVP 2 and the amount of NCVP X is slightly reduced. Since it is believed that
there is only one major site for the initiation of protein synthesis on the poliovirus
genome, we interpret this differential effect on the poliovirus proteins to be an indi-
cation of their relative distance from the initiation site. On this basis, we propose a
gene order for the poliovirus genome (5' -* 3') of NCVP 1, NCVP X, NCVP 2.
The poliovirus genome is a single strand of
ribonucleic acid (RNA) which encodes the amino
acid sequence for a number of proteins. All of
these proteins are apparently formed by prote-
olytic cleavage of a single large polypeptide, sug-
gesting that the genome has only one major site
for initiation of protein synthesis (1, 13, 14; D.
Baltimore et al., In Strategy of the Viral Genome,
Ciba Found. Symp., in press).
This situation affords the opportunity for se-
quencing the genome by treating infected cells
with a drug which specifically inhibits initiation of
protein synthesis. After initiation is inhibited,
synthesis of the protein encoded by the 5'-terminal
end of the genome should be most rapidly de-
pressed followed in order by the proteins encoded
by regions increasingly nearer to the 3'-end.
Pactamycin is known to selectively inhibit ini-
tiation of protein synthesis in bacteria (4, 5) and
in intact or cell-free extracts of rabbit reticulo-
cytes (17; H. F. Lodish et al., Biochemistry, in
press). In this paper, we will show that, in both
uninfected and poliovirus-infected HeLa cells,
there is a transient period of protein synthesis
after addition of pactamycin followed by com-
plete inhibition, suggesting that in these systems,
too, the drug is a selective inhibitor of the initia-
tion of protein synthesis. During the transient
period of protein synthesis after addition of
pactamycin there is a differential inhibition of
synthesis of the various poliovirus-specific poly-
peptides. This allows a tentative ordering of the
regions of the genome which encode the various
polypeptides.
MATERIALS AND METHODS
Infection of cells. The growth of HeLa cells in
spinner-modified Eagle's medium (9) plus 7% horse
serum and their infection with poliovirus in the pres-
ence of 5 ,ug of actinomycin D per ml at 4 X 106 cells
per ml has been described previously (2).
Incorporation studies. Cells at 3 hr after infection
were removed from growth medium and resuspended
at 4 X 106 cells per ml in Earle's saline (9) for labeling.
Radioactive amino acids were added, and samples
were diluted with cold Earle's saline at various times
thereafter. The samples were washed with cold Earle's
saline, resuspended in water, made 0.1 N in NaOH,
incubated for 10 min at 37 C, and precipitated with
cold 5% trichloroacetic acid. The precipitates were
collected on membrane filters (Millipore Corp.) and
counted in a liquid scintillation spectrometer in 10
ml of a mixture of 5 g of 2,5-diphenyloxazole and
100 g of naphthalene in 1 liter of dioxane.
Gel electrophoresis. Cytoplasmic extracts were pre-
pared by swelling cells for 5 min in distilled water at
0 C and homogenizing with a Dounce homogenizer.
Nuclei were removed by centrifugation. The cyto-
plasmic extract was adjusted to 1% mercaptoethanol,
1% sodium dodecyl sulfate, 15% glycerol and boiled
for 2 min. It was then subjected to the Maizel and
Laemmli modification of sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (16; J. V. Maizel,
personal communication) for approximately 3.5 hr at
100 v. For densitometric analysis of the gel patterns,
they were sliced longitudinally into four slices. One of
the center slices was placed on a blotter paper and
lyophilized overnight. The dried gel was taped to
Kodak RB 2 X-ray film and exposed for 2 days. The
autoradiogram was scanned at 500 nm with a Gilford
spectrophotometer modified for gel scanning.
Sucrose gradient analysis. Preparation of cyto-
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plasmic extracts and analysis on sucrose gradients
have been previously described (2, 12, 18).
Materials. [3SImethionine (-6 Ci/mmole) was
prepared as previously described (19) and was pro-
vided by Harvey Lodish.
Pactamycin was provided by Gunther S. Fonken of
the Upjohn Co. Actinomycin D was provided by
Merck, Sharpe and Dohme. [14C]agal hydrolysate was
obtained from New England Nuclear Corp., [3H]me-
thionine was obtained from Amersham/Searle Corp.
(5.2 Ci/mmole), and DL-p-fluorphenylalanine was
obtained from the Sigma Co.
RESULTS
Concentration of pactamycin for selective in-
hibition. At low concentrations (-5 X 10-7 M),
pactamycin selectively inhibits initiation of pro-
tein synthesis in a reticulocyte cell-free system,
but, at higher concentrations, inhibition of trans-
lational steps is evident (17; H. F. Lodish et al.,
Biochemistry, in press). Lacking a specific assay
for initiation in intact poliovirus-infected HeLa
cells, we determined the minimal concentration of
pactamycin which would eventually stop protein
synthesis completely and have used that concen-
tration in further experiments.
In poliovirus-infected HeLa cells, 10-7 M pac-
tamycin was the lowest concentration of the drug
which ultimately produced complete inhibition of
protein synthesis (Fig. 1); 10-8 M produced a
partial inhibition, whereas 10-6 M resulted in
more rapid inhibition. As in a reticulocyte cell-
free system, complete inhibition was not instan-
taneous but rather an accelerating rate of inhibi-
tion occurred over a few minutes.
Effect of pactamycin on the spectrum of proteins
synthesized. To investigate whether pactamycin
selectively decreased the labeling of any of the
poliovirus polypeptides, cells infected for 3 hr
were exposed to 10-7 M pactamycin and 3 min
later [35S]methionine was added. After 7 min of
exposure to the [35S]methionine, the cells were
harvested. A second sample of cells was labeled
with [35S]methionine in the absence of inhibitor
for 5 min followed by a chase of 5 min. Elec-
trophoresis on polyacrylamide gels of the labeled
protein from the two samples followed by auto-
radiography and densitometry of the gels showed
that the protein formed during the exposure to
pactamycin contained much less of the coat pro-
tein precursor polypeptide, NCVP 1 (14, 21),
than that made in the untreated cells (Fig. 2).
The gels resolved more poliovirus-specific poly-
peptides than have previously been noted (21),
and the nomenclature has been extended to in-
clude them. Specifically, NCVP 3 has been split
into two components, NCVP 3a and 3b; NCVP
3a is also lacking in the treated sample. Resolu-
tion of smaller proteins including NCVP X (13,
14) and the capsid proteins (VP) was not achieved
in this analysis so the effect of pactamycin on
their synthesis is not clear.
Rather than attempt to differentiate protein
NCVP X from capsid proteins VP 0, VP 1, and
VP 3, all of which have similar migration rates
during electrophoresis, we chose to inhibit all
capsid protein formation with p-fluorophenylala-
nine (FPA). As shown previously (14), 1.1 mm
FPA prevents cleavage of NCVP 1 to form VP 0,
VP 1, and VP 3 but does not prevent the cleavage
of larger precursors. Therefore, in 1.1 mm FPA,
only three major polypeptides are formed (NCVP
1, NCVP 2, and NCVP X) plus a number of less
prominent ones. Using FPA-treated, infected
cells, a comparison was made between the poly-
peptides made in the presence and absence of
pactamycin. Differentially labeled extracts were
analyzed on a single gel with the data normalized
such that the peaks of NCVP 2 were the same
height (Fig. 3). In the presence of FPA, pacta-
mycin again preferentially inhibited synthesis of
NCVP 1. Furthermore, a small decrease ofNCVP
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FIG. 1. Time course of incorporation ofamino acids
in poliovirus-infected HeLa cells at different concen-
trations of pactamycin. At 3 hr after infection, cells
were harvested and resuspended in Earle's saline at
4 X 106 cells/ml. The cells were separated into four
equal portions and pactamycin at a final concentration
of10-6M (0), 10-7M (0), or 10 M (A), or no drug
(X) was added to each. Radioactive [14C]agal hy-
drolysate (0.5 ,uCi/ml) was added to each sample
simultaneously with the pactamycin. Samples were
taken at the indicated times and treated as described
in Materials and Methods.
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FIG. 2. Polyacrylamide gel electrophoresis ofcytoplasmic extracts ofpoliovirus-infected cells in the absence (a)
or presence (b) ofpactamycin. Tracings of an autoradiogram of the acrylamide gels are shown. At 3 hr after in-
fection, cultures of2 X 107 cells were suspended in Earle's saline. After 10 min, (a) was labeled with [35S] methi-
onine (5 ,uCi/ml) for S min and chased for 5 min with a 105 excess of cold methionine, and (b) was made 10J7M
in pactamycin and labeled 3 min later with [35S] methionine and incubation was stopped at 10 min.
NCVP 3b
NCVPI NCVPI1/2 NCVP2 NCVP3a NCVPX
1>~~~~~~~~~~~~~~~~~~~~~~~1&1-0 90KAK( R030 40 50FR ACT ION NUM BER 60 70 80FIG. 3. Polyacrylamide gel electrophoresis ofcytoplasmic extracts ofp-fluorophenylalanine (FPA)-treated cells.Poliovirus-infected cells 3 hr after infection at 4 X 106 cells/ml were made 1.1 mm FPA in Earle's saline andincubated for 10 min. To one culture, 100 ,uCi of [3H]methionine per ml was then added and cells were labeledfor 25 min (0). To the other culture, 10-ii pactamycin was added, cells were incubated for 2.5 min, 60 IACi-
of [35S]methionine per ml was added, and incubation was continued for an additional 22.5 min (-). Cytoplasmic
extracts were prepared separately, and portions of each were mixed and analyzed by electrophoresis. Radio-
activity in gel slices was normalized to 100 for both (8H) and (35S) in fraction 36. This represents 4,840 countsl
min in the [3Hlmethionine sample (0) and 2,149 counts/min in the [35S]methionine sample (0).
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X relative to NCVP 2 was evident in the treated
sample along with the elimination of NCVP 3a.
Effects on other minor peaks were evident but
cannot be interpreted until the relationship of
these proteins to the major ones is clarified.
Effect of pactamycin on protein synthesis and
polyribosomes. The results in Fig. 2 and 3 were
reproducible in other experiments, but attempts
to change the ratio of NCVP 2 to NCVP X were
unsuccessful even when the time between addition
of pactamycin and addition of labeled amino acid
was lengthened. This led us to look further at the
effects of the drug on uninfected and infected
HeLa cells.
In the reticulocyte system, even at 25 C, only
1 to 2 min was required to give a complete cessa-
tion of synthesis (H. F. Lodish et al., Biochem-
istry, in press), whereas poliovirus-infected HeLa
cells required more than 6 min (Fig. 1). This could
reflect the time necessary for entry of the drug
into the cells or the longer messenger RNA for
poliovirus proteins than for hemoglobin, or both.
If the length of the messenger RNA is a factor,
uninfected HeLa cells should cease synthesis
sooner than infected cells. To test this possibility,
infected and uninfected cells were simultaneously
exposed to 10-7 M pactamycin and [35S]methio-
nine. In uninfected cells, the accumulation of
labeled protein in the treated sample deviated
from that in an untreated sample within 2 min
after treatment and inhibition was 90% complete
by about 4 min (Fig. 4b). In contrast, in the
presence of pactamycin, the poliovirus-infected
cells maintained their rate of synthesis near that
of the untreated, infected cells for about 4 min
and 90% inhibition occurred at about 7 min
(Fig. 4a). Similar results have been obtained by
measuring rates of synthesis in uninfected and
infected cells by using 1-min pulses of [3H]leucine.
In uninfected HeLa cells, pactamycin markedly
reduced the average size of the polyribosomes by
2 min after addition and by 5 min few polyribo-
somes were evident (Fig. 5). In poliovirus-infected
cells, the drug required 5 min to decrease the size
of the major polyribosome peak. A slow disap-
pearance of polyribosomes then ensued which was
complete by 25 min (Fig. 6). Most of the [35S]me-
thionine incorporated during pactamycin treat-
ment was initially localized in polyribosomes and
was released from the polyribosomes by 25 min
after the addition of the drug (Fig. 7). The results
with uninfected cells are consistent with a prefer-
ential blockage of initiation in pactamycin-treated
cells. The results with infected cells are also
consistent with this idea but are less clear and will
be discussed below.
DISCUSSION
Our hope in performing these experiments was
to provide a method for sequencing the gene order
on the poliovirus genome. Because it appears that
the genome is translated into a single polypeptide
TIME IN MINUTES
FIG. 4. Time course of incorporation of [35S]methionine in uninfected and poliovirus-infected HeLa cells. (a)
Poliovirus-infected cells were treated as in Fig. I and labeled with [85S]methionine (2 ACi/mI) either in the presence
(0) or the absence (X) of 107 M pactamycin. (b) Uninfected cells were treated as in Fig. I and labeled with
[35S]methionine (2 ACi/ml) either in the presence (0) or the absence (X) of 1J7 M pactamycin.
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FIG. 5. Sucrose gradient pattern of polyribosomes from pactamycin-treated uninfected HeLa cells. Cells sus-
pended in Earle's saline at 4 X 106/ml were adjusted to 10-7 M pactamycin. Samples of 2 X 107 cells were placed
into cold Earle's saline at 0, 2, and 5 min after pactamycin addition. Cytoplasmic extracts were prepared and
layered onto 15 to 30% sucrose gradients made up in 0.01 M tris (hydroxymethyl)aminomethane, pH 7.4, 0.01 M
NaCI, and0.0015 M MgCI2 . Centrifugation wasfor 100 min at 25,000 rev/min in the Spinco SW27 rotor at 4 C.
chain, this would be equivalent to sequencing the
order of proteins in this polypeptide.
The experiments suggest that NCVP 1 is en-
coded by information at the 5' end of the genome.
The reasons for this conclusion are: (i) within
2.5 to 3 min after pactamycin treatment only
NCVP 1 synthesis is markedly inhibited and (ii)
the evidence for translation of the viral genome
into a single polypeptide implies that only one
initiation site exists on the viral genome (12-14)
and this should be at the 5' end (3). This conclu-
sion agrees with the genetic mapping data of
Cooper which placed the capsid proteins at an
end of the genome (7).
Only a tentative conclusion can be made about
the location of the other two major viral genes,
those for NCVP 2 and NCVP X, because their
specific activities (Fig. 3) are not very different.
The differences are reproducible, however, and so
the gene for NCVP 2 would appear to be at the
3' end of the genome because its synthesis is least
affected by pactamycin. NCVP X would then be
between NCVP 1 and NCVP 2 because its syn-
thesis is more severely inhibited by pactamycin
than the synthesis of NCVP 2.
Polypeptides smaller than NCVP X have not
been investigated. The intermediate peaks, which
are not made in molar amounts relative to NCVP
1, NCVP 2, and NCVP X, are hard to interpret
until their relation to the other proteins has been
determined by, for instance, peptide composition.
The coincidental behavior ofNCVP 1 and NCVP
3a suggests a relation between these two species.
A gene order of NCVP 1-NCVP X-NCVP 2
might explain the existence ofNCVP 0 in infected
cells treated with either amino acid analogues (13,
14) or high temperature (1; D. Baltimore et al.,
In The Strategy of the Viral Genome, Ciba Found.
Symp., in press). NCVP 0 is always a broad peak
and therefore is probably two (or more) species
of protein. It could consist of one polypeptide
consisting ofNCVP 1 plus NCVP X and a second
of NCVP X plus NCVP 2.
Inhibition of polypeptide elongation in polio-
virus-infected cells. Our experiments were sug-
gested by the observation that in a reticulocyte
cell-free system, inhibition of initiation is the
major result of adding a critical concentration of
pactamycin (H. F. Lodish et al., Biochemistry, in
press). In uninfected HeLa cells, at 10-7 M pacta-
mycin, the time course of breakdown of poly-
ribosomes paralleled the inhibition of protein
synthesis, suggesting that initiation of protein
synthesis was also selectively affected in this
system. In poliovirus-infected cells, however, al-
though the time course of inhibition was length-
ened as would be predicted from the existence of a
long messenger RNA translated from a single
initiation site, there are two anomalies. First,
synthesis stops too rapidly. The viral genome is
about 2.5 X 106 daltons (11), whereas the average
cell messenger RNA is about 0.5 X 106 (15;
Baltimore, unpublished data). It should therefore
require about five times as long for complete
inhibition of viral protein synthesis than of cell
protein synthesis. The measured difference was
no more than twofold. Second, in infected cells,
the polyribosomes do not disaggregate in parallel
with the inhibition of protein synthesis. A pro-
gressive diminution of polyribosome size and
number does occur, but, by 10 min, when incor-
poration is no longer detectable, polyribosomes
are still present.
From these data, it appears that in infected
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FIG. 6. Sucrose gradient analysis of polyribosomes
from poliovirus-infected HeLa cells. At 3 hr after
infection, cells were centrifuged and resuspended at
4 X 106 cells per ml in Earle's saline. Pactamycin was
then added to 10-7 M. Samples of 2 X 107 cells were
taken at 0, 5, 10, 15, and 25 min after the addition of
pactamycin. Sucrose gradient analysis of cytoplasmic
extracts was carried out as in Fig. 5. Only the portion
of the gradients displaying material larger than 80S is
shown.
cells 10-7 M pactamycin inhibits both initiation
and elongation of polypeptide chains. This could
be the result of the long time necessary for com-
plete translation of the long viral messenger RNA
which allows a high intracellular concentration of
the drug to accumulate, leading to a rapid initial
block of polypeptide initiation followed by a
slower blockage of elongation. The irreversability
of pactamycin inhibition (6, 10; R. Taber and D.
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FIG. 7. Sucrose gradient analysis of polyribosomes
from poliovirus-infected HeLa cells. To cells, treated as
in Fig. 6, [3SJmethionine (-2 MCi/mi) was added at
3 min after the addition of10-7 M pactamycin. Samples
of2 X 107 cells were taken into cold Earle's saline at
3.5 min (0), 10 min (X), and 25 min (A) after pac-
tamycin addition. Sucrose gradient analysis of cyto-
plasmic extracts was carried out as in Fig. 5, and acid-
precipitable radioactivity was determined. The radio-
activity in each gradient was summed (3.5 min, 62,812;
10 min, 381,110; 25 min, 405,156) and normalized to
the 25-min total to make the proportion of counts in
polyribosomes readily discernible. Single ribosomes
(74S) sedimented at fraction 16.
Rekosh, unpublished data), in fact, suggests that
an increasing intracellular concentration of the
drug may accumulate.
Another possible explanation for the slow loss
of polyribosomes is that translation by one ribo-
some in a polyribosome may by chance become
inhibited by the drug, and, because of the large
size of the viral polyribosome, a larger number of
ribosomes would be inhibited, whereas in a
smaller polyribosome this effect would be less
evident.
Whatever the reason for the apparent inhibition
of polypeptide chain elongation by pactamycin in
infected cells, it limits the types of experiments
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which can be performed by causing an asynchrony
of run-off of ribosomes. Probably for this reason,
we have been limited to about 3 min between the
times of addition of pactamycin and the labeled
amino acid; although longer times have been
tried, they merely diminish the amount of radio-
activity incorporated without changing the pat-
terns on polyacrylamide gels from those in Fig.
2 and 3.
Further utility of pactamycin fot genetic map-
ping. It may be possible to use pactamycin in
experiments like those reported here to investigate
a number of questions in virology and cell bi-
ology. It should be generally true that the syn-
thesis of proteins encoded by separate monocis-
tronic messenger RNA species will be inhibited
rapidly and coincidentally by pactamycin. Pro-
teins made from a single messenger RNA and
formed by proteolytic cleavage of a precursor
polypeptide should be inhibited sequentially. One
specific problem amenable to solution is whether
the two group A arbovirus (togavirus) proteins
are formed by cleavage from a single precursor
(20; E. Ginsberg and B. Burge, unpublished data).
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ADDENDUM IN PROOF
After submitting this communication, we became
aware of similar experiments performed by Summers
and Maizel (Proc. Nat. Acad. Sci. U.S.A., in press).
Their data also indicate that NCVP 1 is coded for by
RNA at or near the 5' end of the genome.
Recently, by extending the pactamycin technique,
we have sequenced the coat proteins within NCVP 1
and obtained an order (5' -- 3') of VP 4, VP 2, VP 3,
VP 1 (D. Rekosh, in preparation).
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